Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Laryngitis
ADR ID BADD_A02486
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.13      Upper respiratory tract infections
11.01.13.001      Laryngitis
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.03      Upper respiratory tract infections NEC
22.07.03.001      Laryngitis
Description A disorder characterized by an inflammatory process involving the larynx. [CTCAE] Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS. [MeSH]
MedDRA Code 10023874
MeSH ID D007827
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute laryngitis | Chronic laryngitis | Laryngitis | Laryngitis (acute) | Laryngitis acute NOS | Laryngitis chronic | Laryngitis chronic NOS | Laryngitis NOS | Infective laryngitis | Laryngitides
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01942Riluzole--
BADD_D01956Rivastigmine tartrate--
BADD_D01961Rofecoxib--
BADD_D01966Ropinirole--
BADD_D01978Ruxolitinib0.001066%
BADD_D01981Salmeterol--
BADD_D01989Saquinavir mesylate--
BADD_D02002Selegiline--
BADD_D02010Sertraline--
BADD_D02011Sertraline hydrochloride--
BADD_D02016Sibutramine--
BADD_D02017Sibutramine hydrochloride--
BADD_D02018Sildenafil--
BADD_D02028Sirolimus0.000686%
BADD_D02047Sodium oxybate0.007873%
BADD_D02055Somatropin--
BADD_D02105Tacrolimus--
BADD_D02151Temsirolimus--
BADD_D02165Teriflunomide--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02224Tiotropium bromide--
BADD_D02225Tiotropium bromide monohydrate--
BADD_D02232Tobramycin--
BADD_D02236Tofacitinib0.016212%
BADD_D02241Tolcapone--
BADD_D02247Topiramate--
BADD_D02254Tramadol--
BADD_D02325Valdecoxib--
BADD_D02334Vandetanib--
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages